Kynurenic Acid Is a Predictive Prognostic Metabolic Marker in ST-Elevation Myocardial Infarction

Xiaolin Zhang; Miaohan Qiu; Kun Na; Minghui Cheng; Haixu Song; Ning Zhao; Dan Liu; Chenghui Yan; Yaling Han

doi:10.1155/cdr/9123654

Cardiovascular Therapeutics (Jan 2025)

Kynurenic Acid Is a Predictive Prognostic Metabolic Marker in ST-Elevation Myocardial Infarction

Xiaolin Zhang,
Miaohan Qiu,
Kun Na,
Minghui Cheng,
Haixu Song,
Ning Zhao,
Dan Liu,
Chenghui Yan,
Yaling Han

Affiliations

Xiaolin Zhang: State Key Laboratory of Frigid Zone Cardiovascular Disease
Miaohan Qiu: State Key Laboratory of Frigid Zone Cardiovascular Disease
Kun Na: State Key Laboratory of Frigid Zone Cardiovascular Disease
Minghui Cheng: State Key Laboratory of Frigid Zone Cardiovascular Disease
Haixu Song: State Key Laboratory of Frigid Zone Cardiovascular Disease
Ning Zhao: State Key Laboratory of Frigid Zone Cardiovascular Disease
Dan Liu: State Key Laboratory of Frigid Zone Cardiovascular Disease
Chenghui Yan: State Key Laboratory of Frigid Zone Cardiovascular Disease
Yaling Han: State Key Laboratory of Frigid Zone Cardiovascular Disease

DOI: https://doi.org/10.1155/cdr/9123654
Journal volume & issue: Vol. 2025

Abstract

Read online

Conclusions: The KYNA level may correspond to the underlying status of acute myocardial infarction and is a promising biomarker for predicting STEMI progression.

Published in Cardiovascular Therapeutics

ISSN: 1755-5914 (Print); 1755-5922 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Therapeutics. Pharmacology; Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
Website: https://onlinelibrary.wiley.com/journal/4702

About the journal